The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, pharmacokinetics and anti-tumor activity of RP12146, a PARP1/2 inhibitor, in patients with locally advanced or metastatic solid tumors.
 
Piotr Jan Wysocki
No Relationships to Disclose
 
Maciej Tadeusz Lubaś
No Relationships to Disclose
 
Mateusz Łobacz,
No Relationships to Disclose
 
Ewa Kalinka-Warzocha
No Relationships to Disclose
 
Piotr Tomczak
No Relationships to Disclose
 
Michal Kwiatek
No Relationships to Disclose
 
Iwona A. Lugowska
Honoraria - Agenus; Amgen; AstraZeneca; BeiGene; BMS; Celon Pharma; Cullinan Oncology; Jacobio; Janssen; Loxo; Macrogenics; Menarini; MSD; Pfizer; Rhizen Pharmaceuticals; ROCHE; Sanofi; Sanofi; Takeda
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AGENUS (Inst); ROCHE (Inst)
Travel, Accommodations, Expenses - BMS
 
Martin Smakal
No Relationships to Disclose
 
Dominik Chraniuk
No Relationships to Disclose
 
Bohuslav Melichar
No Relationships to Disclose
 
Beate Markiewicz-Bialek
No Relationships to Disclose
 
Kasi V. Routhu
Employment - Rhizen Pharmaceuticals
 
Prajak J. Barde
Employment - Rhizen Pharmaceuticals
 
Ajit Nair
Employment - Rhizen Pharmaceuticals